Tenaya Therapeutics (TNYA) Return on Capital Employed (2021 - 2026)
Tenaya Therapeutics' quarterly Return on Capital Employed came in at 69.12% in Q1 2026, up 2403.0% year-on-year from 2.76% in Q1 2025, and up 18.15% quarter-over-quarter from 84.45% in Q4 2025.
Tenaya Therapeutics has reported Return on Capital Employed for 6 years, with the latest figure at 69.12% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 2403.0% year-over-year to 69.12%; the trailing twelve-month figure through Mar 2026 stood at 69.12% (up 2403.0% YoY), and the FY2025 full-year result was 79.1%, up 1061.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 69.12%, up from 84.45% in the prior quarter.
- The five-year high for Return on Capital Employed was 32.59% in Q1 2022, with the low at 101.45% in Q4 2024.
- Average Return on Capital Employed over 5 years is 72.73%, with a median of 80.69% recorded in 2024.
- Year-over-year, Return on Capital Employed plunged 3083 bps in 2022 and surged 2403 bps in 2026.
- Tracing TNYA's Return on Capital Employed over 5 years: stood at 55.01% in 2022, then plunged by 50 bps to 82.4% in 2023, then retreated by 23 bps to 101.45% in 2024, then rose by 17 bps to 84.45% in 2025, then increased by 18 bps to 69.12% in 2026.
- The last three Return on Capital Employed figures came in at 69.12% (Q1 2026), 84.45% (Q4 2025), and 96.86% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | -69.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.12% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -96.86% |
| Jun 30, 2025 | -85.54% |
| Mar 31, 2025 | -93.15% |
| Dec 31, 2024 | -101.45% |
| Sep 30, 2024 | -90.45% |
| Jun 30, 2024 | -80.69% |
| Mar 31, 2024 | -82.77% |
| Dec 31, 2023 | -82.40% |
| Sep 30, 2023 | -71.55% |
| Jun 30, 2023 | -63.49% |
| Mar 31, 2023 | -52.79% |
| Dec 31, 2022 | -55.01% |
| Sep 30, 2022 | -52.48% |
| Jun 30, 2022 | -41.70% |
| Mar 31, 2022 | -32.59% |
| Dec 31, 2021 | -24.17% |
| Sep 30, 2021 | -24.70% |